Amala Cancer Research Centre, Thrissur, Kerala, India.
Integr Cancer Ther. 2012 Jun;11(2):172-82. doi: 10.1177/1534735411400310. Epub 2011 Jul 19.
Homoeopathic medicines treat diseases, including cancer, using ultradiluted preparations. Earlier studies indicated that homoeopathic medicines are cytotoxic to tumor cells and reduced animal tumors. However, the mechanism of homoeopathic medicines at the cellular level is not known.
The following drugs were used in the study: Ruta 200C, Carcinosinum 200C, Hydrastis 200C, Thuja 200C, and Thuja 1M. These drugs were tested for their ability to induce apoptosis as seen by morphology, DNA laddering, expression of genes related to apoptosis, and TUNEL assay. Similarly, the effect of homoeopathic medicines on apoptosis was measured by microarray analysis. Activity of Ruta 200C was compared with that of the mother tincture.
Ruta 200C produced morphological changes in the Dalton's lymphoma ascites tumor cells and induced DNA laddering. Carcinosinum 200C increased apoptotic gene p53 and Ruta 200C decreased antiapoptotic gene Bcl2. Administration of potentiated homoeopathic drugs to tumor-bearing mice induced TUNEL-positive cells in the tumor, showing increased apoptosis of tumor cells. Microarray analysis of cells treated with homoeopathic drugs indicated that many enzymes related to apoptosis were increased by homoeopathic drugs.
These data indicate that apoptosis is one of the mechanisms of tumor reduction of homeopathic drugs. A comparison of potentiated drugs with their mother tincture indicated that the potentiated drugs have biological activity similar to that of their mother tincture in spite of ultradilution.
顺势疗法药物使用超稀释制剂治疗疾病,包括癌症。早期的研究表明,顺势疗法药物对肿瘤细胞具有细胞毒性,并能减少动物肿瘤。然而,顺势疗法药物在细胞水平上的作用机制尚不清楚。
本研究使用了以下药物:Ruta 200C、Carcinosinum 200C、Hydrastis 200C、 Thuja 200C 和 Thuja 1M。通过形态学、DNA 梯状带、与凋亡相关基因的表达以及 TUNEL 检测,检测这些药物诱导凋亡的能力。同样,通过微阵列分析测量顺势疗法药物对凋亡的影响。比较了 Ruta 200C 的活性与母液的活性。
Ruta 200C 使 Dalton 淋巴瘤腹水肿瘤细胞发生形态变化,并诱导 DNA 梯状带。Carcinosinum 200C 增加了凋亡基因 p53,而 Ruta 200C 降低了抗凋亡基因 Bcl2。给荷瘤小鼠施用增强型顺势疗法药物,可使肿瘤中出现 TUNEL 阳性细胞,表明肿瘤细胞凋亡增加。用顺势疗法药物处理的细胞的微阵列分析表明,许多与凋亡相关的酶被顺势疗法药物所增加。
这些数据表明,凋亡是顺势疗法药物减少肿瘤的机制之一。与母液相比,增强型药物表明,尽管经过超稀释处理,增强型药物仍具有与其母液相似的生物学活性。